Article Sidebar

PDF (Tiếng Việt)
Published: 2022-06-15
Abstract Views: 354
Views PDF (Tiếng Việt): 309
DOI: https://doi.org/10.52852/tcncyh.v155i7.802
Issue
Vol. 155 No. 7 (2022)
Section
Các bài báo
How to Cite
Dung, P. T. V. ., & Tuấn, N. N. (2022). 4. Late-onset abscess after Acid Hyaluronic fillers injection. Journal of Medical Research, 155(7), 21-25. https://doi.org/10.52852/tcncyh.v155i7.802

4. Late-onset abscess after Acid Hyaluronic fillers injection

Pham Thi Viet Dung, Nguyen Ngoc Tuan

Main Article Content

Abstract

Introduction: Acid Hyaluronic filler injections are popular for facial rejuvenation and many other cosmetic purposes recently. Besides of the advantages, there are many complications related to the materials source and the injection technique. Clinical case: The authors introduced 3 clinical cases of late-onset abscess after acid hyaluronic fillers injection in the facial area. The time to onset of infection is 1 - 3 years after injection. Bacteria that caused these abscesses were P. aeruginosa or S. aureus which were sensitive to antibiotics. All patients were effectively treated with abscess extraction and antibiotic therapy. Clinical discussion: This article discussed the symptoms of the late-onset abscesses after injection of acid hyaluronic fillers as well as the causes and treatment. Conclusion: The late-onset infection may be related with biofilm formation or glandulae sebaceae infection. The first-line of therapy is drainage and antibiotics.

Article Details

Keywords

Abcess, Filler, acid hyaluronic, late-onset, biofilm

References

1. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64(1):1-34. quiz 35-36.
2. Conrad K, Alipasha R, Thiru S, Kandasamy T. Abscess formation as a complication of injectable fillers. Mod Plast Surg. 2015;05:14-18.
3. Marusza W, Olszanski R, Sierdzinski J, et al. Treatment of late bacterial infections resulting from soft-tissue filler injections. Infect Drug Resist. 2019;12:469-480.
4. Saththianathan M, Johani K, Taylor A, et al. The role of bacterial biofilm in adverse soft-tissue filler reactions: A combined laboratory and clinical study. Plast Reconstr Surg. 2017;139(3):613-621.
5. Alhede M, Bjarnsholt T. Are biofilms responsible for the adverse effects experienced following soft-tissue fillers? Future Microbiol. 2014;9(8):931-933.
6. Sadashivaiah AB, Mysore V. Biofilms: Their role in dermal fillers. J Cutan Aesthetic Surg. 2010;3(1):20-22.
7. Dayan SH, Arkins JP, Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg FPS. 2011;27(1):23-28.
8. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-193.
9. De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015;8:205-214.